Emam SH - Search Results

1

Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.

Khalil NA, Kamal AM, Emam SH. Khalil NA, et al. Among authors: emam sh. Biol Pharm Bull. 2015;38(5):763-73. doi: 10.1248/bpb.b14-00867. Biol Pharm Bull. 2015. PMID: 25947922 Free article.

2

Synthesis of New N¹-Substituted-5-aryl-3-(3,4,5-trimethoxyphenyl)-2-pyrazoline Derivatives as Antitumor Agents Targeting the Colchicine Site on Tubulin.

Elmeligie S, Khalil NA, Ahmed EM, Emam SH, Zaitone SA. Elmeligie S, et al. Among authors: emam sh. Biol Pharm Bull. 2016;39(10):1611-1622. doi: 10.1248/bpb.b16-00277. Biol Pharm Bull. 2016. PMID: 27725438 Free article.

3

New 3-Substituted-2-(4-hydroxyanilino)pyridine Derivatives: Synthesis, Antitumor Activity, and Tubulin Polymerization Inhibition.

Elmeligie S, Khalil NA, Ahmed EM, Emam SH. Elmeligie S, et al. Among authors: emam sh. Arch Pharm (Weinheim). 2017 Feb;350(2). doi: 10.1002/ardp.201600256. Epub 2017 Feb 2. Arch Pharm (Weinheim). 2017. PMID: 28150327

4

Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity.

Hassan RA, Emam SH, Hwang D, Kim GD, Hassanin SO, Khalil MG, Abdou AM, Sonousi A. Hassan RA, et al. Among authors: emam sh. Bioorg Chem. 2022 Jan;118:105487. doi: 10.1016/j.bioorg.2021.105487. Epub 2021 Nov 13. Bioorg Chem. 2022. PMID: 34798455

5

Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity.

Sonousi A, Hassan RA, Osman EO, Abdou AM, Emam SH. Sonousi A, et al. Among authors: emam sh. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2644-2659. doi: 10.1080/14756366.2022.2118735. J Enzyme Inhib Med Chem. 2022. PMID: 36146940 Free PMC article.

6

Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells.

Emam SH, Sonousi A, Osman EO, Hwang D, Kim GD, Hassan RA. Emam SH, et al. Bioorg Chem. 2021 Feb;107:104630. doi: 10.1016/j.bioorg.2021.104630. Epub 2021 Jan 7. Bioorg Chem. 2021. PMID: 33476864

7

Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies.

Emam SH, Hassan RA, Osman EO, Hamed MIA, Abdou AM, Kandil MM, Elbaz EM, Mikhail DS. Emam SH, et al. Drug Dev Res. 2023 May;84(3):433-457. doi: 10.1002/ddr.22037. Epub 2023 Feb 13. Drug Dev Res. 2023. PMID: 36779381

8

Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone-based derivatives as DHFR inhibitors.

Osman EO, Emam SH, Sonousi A, Kandil MM, Abdou AM, Hassan RA. Osman EO, et al. Among authors: emam sh. Drug Dev Res. 2023 Aug;84(5):888-906. doi: 10.1002/ddr.22060. Epub 2023 Apr 13. Drug Dev Res. 2023. PMID: 37052308

9

Combretastatin A-4 based compounds as potential anticancer agents: A review.

Omar MH, Emam SH, Mikhail DS, Elmeligie S. Omar MH, et al. Among authors: emam sh. Bioorg Chem. 2024 Dec;153:107930. doi: 10.1016/j.bioorg.2024.107930. Epub 2024 Oct 29. Bioorg Chem. 2024. PMID: 39504638 Review.

10

New trends in synthetic drugs and natural products targeting 20S proteasomes in cancers.

Atta H, Alzahaby N, Hamdy NM, Emam SH, Sonousi A, Ziko L. Atta H, et al. Among authors: emam sh. Bioorg Chem. 2023 Apr;133:106427. doi: 10.1016/j.bioorg.2023.106427. Epub 2023 Feb 17. Bioorg Chem. 2023. PMID: 36841046 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters